Food-bound iron in a Mumbai trial did not replicate supplement-associated microbiome shifts, researcher says

Dr. Saurabh Mehta of Cornell University presented exploratory findings from a randomized controlled trial in urban slums of Mumbai that tested whether food-bound iron delivered through biofortified crops affects infant microbiome development.

Mehta described the intervention—a program that procured about nine tons of biofortified crops and delivered a cyclical menu three times daily within about five minutes’ walking distance of participating children’s homes—and said the trial ran for nine months. "We were happy to see that the iron delivered through a food-bound approach didn't have the adverse impact that we had seen with iron supplements," Mehta said, describing inferred increases in antibiotic-biosynthesis pathways and antioxidant metabolism consistent with potentially stronger colonization resistance and lower inferred pathogen abundance.

He cautioned the results are hypothesis-generating: the trial was not designed with these microbiome measures as primary outcomes, absorption measures were not directly assessed, and morbidity reporting and in vitro validation are still needed. "Results remain speculative without in vitro validation," Mehta said, and he urged further testing in other populations despite noting the global prevalence of urban slum residence.

Mehta also described methodological strengths—shotgun metagenomics and multiple time points across nine months—while noting caveats about generalizability and that functional inference does not equal direct evidence of metabolic activity. He closed by crediting team members and collaborators for the work and by urging follow-up studies to test whether food-based biofortification can influence pathogen carriage and the gut resistome.